ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

CCOPs Extended One Year While Waiting Evaluation

May 17, 1985

Funding opportunities listed.

November 12, 2004